Role of non-major histocompatibility complex antigens in the rejection of transplanted myoblasts

Transplantation

Volumn 63, Issue 6, 1997, Pages 893-899

  Boulanger, Annie ^a   Asselin, Isabelle ^a   Roy, Raynald ^a   Tremblay, Jacques P ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; GAMMA INTERFERON; GRANZYME B; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CULTURE MEDIUM; FEMALE; GRAFT REJECTION; IMMUNOREACTIVITY; ISOGRAFT; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; MYOBLAST; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE;

ACTINS; ANIMALS; ANIMALS, NEWBORN; ANTIBODY FORMATION; CELLS, CULTURED; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS; IMMUNITY, CELLULAR; INTERFERON TYPE II; ISOANTIBODIES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MICE, INBRED STRAINS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; POLYMERASE CHAIN REACTION; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC;

EID: 0030892255     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199703270-00016     Document Type: Article

References (31)

1. Kunkel LM, Monaco AP, Middlesworth W, Ochs HD, Latt SA. Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci USA 1985; 82: 4778.
2. Ray PN, Beifall B, Duff C, et al. Cloning of the breakpoint of an X:21 translocation associated with Duchenne muscular dystrophy. Nature 1985; 318: 672.
3. McArdle A, Edwards RHT, Jackson MJ. Effects of contractile activity on muscle damage in the dystrophin-deficient mdx mouse. Clin Sci 1991; 80: 367.
4. Menke A, Jockusch H. Decreased osmotic stability of dystrophinless muscle cells from the mdx mouse. Nature 1991; 349: 69.
5. Sacco P, Jones DA, Dick JRT, Urbova G. Contractile properties and susceptibility to exercise-induced damage of normal and mdx mouse tibialis anterior muscle. Clin Sci 1992; 82: 227.
6. Partridge TA. Myoblast transfer: a possible therapy for inherited myopathies? Muscle Nerve 1991; 14: 197.
7. Morgan JE, Partridge TA. Cell transplantation and gene therapy in muscular dystrophy. Bioessays 1992; 14: 641.
8. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989; 337: 176.
9. Huard J, Verreault S, Roy R, Tremblay M, Tremblay JP. High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J Clin Invest 1994; 93: 586.
10. Kinoshita I, Vilquin JT, Guérette B, Asselin I, Roy R, Tremblay JP. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 1994; 17: 1407.
11. Vilquin JT, Wagner E, Kinoshita I, Roy R, Tremblay JP. Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. J Cell Biol 1995; 131: 975.
12. Huard J, Bouchard JP, Roy R, et al. Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve 1992; 15: 550.
13. Tremblay JP, Malouin F, Roy R, et al. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 1993; 2: 99.
14. Mendell JR, Kissel JT, Amato AA, et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med 1995; 333: 832.
15. Lindahl KF. Minor histocompatibility antigens. Trends Genet 1991; 7: 219.
16. Roopenian DC, Davis AP, Christianson GJ, Mobraaten LE. The functional basis of minor histocompatibility loci. J Immunol 1993; 151: 4595.
17. Goulmy E, Termijtelen A, Bradley BA, Van Rood JJ. Alloimmunity to human H-Y. Lancet 1976; 2: 1206.
18. Wernig A, Irintchev A. Bystander damage of host muscle caused by implantation of MHC-compatible myogenic cells. J Neurol Sci 1995; 130: 190.
19. Eichwald EJ, Silmser CR. Skin. Transplant Bull 1955; 2: 148.
20. Goulmy E, Termijelen A, Bradley BA, Van Rood JJ. Y antigen killing by T cells of women is restricted by HLA. Nature 1977; 266: 544.
21. Wang W, Meadows LR, Den Haan HM, et al. Human H-Y: a male specific histocompatibility antigen derived from the SMCV protein. Science 1995; 269: 1588.
22. Cossu G, Zani B, Coletta M, Bouchèf M, Pacifici M, Molinarol M. In vitro differentiation of satellite cells isolated from normal and dystrophic mammalian muscles: a comparison with embryonic myogenic cells. Cell Differ 1980; 9: 357.
23. Guérette B, Roy R, Tremblay M, et al. Increased granzyme B mRNA after alloincompatible myoblast transplantation. Transplantation 1995; 60(9): 1011.
24. Guérette B, Tremblay G, Vilquin JT, et al. Increased interferon-γ mRNA expression following alloincompatible myoblast transplantation is inhibited by FK506. Muscle Nerve 1996; 19: 829.
25. Grounds M, Partridge TA, Sloper JC. The contribution of exogenous cells to regenerating skeletal muscle: an isoenzyme study of muscle allografts in mice. J Pathol 1980; 132: 325.
26. Watt DJ, Morgan JE, Partridge TA. Allografts of muscle precursor cells persist in the non-tolerized host. Neuromuscul Disord 1991; 1: 345.
27. Hoffman EP, Morgan JE, Watkins SC, Partridge TA. Somatic reversion/suppression of the mouse mdx phenotype in vivo. J Neurol Sci 1990; 99: 9.
28. Roy R, Dansereau G, Tremblay JP, Belles-Isles M, Labrecque C, Bouchard JP. Major histocompatibility complex (MHC) antigens expression on human myoblasts. Transplant Proc 1991; 23: 799.
29. Grounds MD, Lai MC, Fan Y, Codling JC, Beilharz MW. Transplantation in the mouse model - the use of a Y-chromosome-specific DNA clone to identify donors cells in situ. Transplantation 1991; 52: 1101.
30. Fan Y, Maley M, Belharz M, Grounds M. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 1996; 19: 853.
31. Fan Y, Beilharz M, Grounds M. A potential alternative strategy for myoblast transfer therapy: the use of sliced muscle grafts. Cell Transplant 1996; 5: 421.